INTRODUCTION The Rehabilitation EnAblement in CHronic Heart Failure (REACH-HF) trial is part of a research programme designed to develop and evaluate a health professional facilitated, home-based, self-help rehabilitation intervention to improve self-care and health-related quality of life in people with heart failure and their caregivers. The trial will assess the clinical effectiveness and co...

Heart failure (HF) is an important cardiovascular disease in its own right, a risk factor for disease (atrial fibrillation, stroke, coronary artery disease), and a consequence of other diseases (e.g. rheumatic, hypertensive or coronary artery disease), therefore posing a triple threat to public health [6-12]. Heart failure is an important cause of hospitalisation and incurs huge costs to the in...

Heart failure (HF) and coronary insufficiency are common amongst surgical and critical care patients. Both are chronic conditions interrupted by acute episodes. HF activates neurohormonal mechanisms that worsen renal and cardiac function. Acute heart failure (AHF) commonly presents with dyspnoea as a consequence of systolic and / or diastolic dysfunction. Goals of treatment are symptom relief, ...

AIMS Several models for predicting the prognosis of heart failure (HF) patients have been developed, but all of them focus on a single outcome variable, such as all-cause mortality. The purpose of this study was to develop a multistate model for simultaneously predicting survival and HF-related hospitalization in patients discharged alive from hospital after recovery from acute HF. METHODS AN...

There are many reviews that discuss the role of biomarkers in cardiovascular disease (CVD) and heart failure (Braunwald, 2008; Chen et al., 2010; Hochholzer et al., 2010), but little information exists regarding the presence and usefulness of biomarkers for heart failure in myocarditis and dilated cardiomyopathy (DCM) patients. Heart failure (HF) is the end consequence of many CVDs including at...

AIMS Improved prognosis of patients with chronic systolic heart failure by treatment with beta-blockers has been shown in several randomized controlled multicentre trials. However, in clinical practice only a part of heart failure patients meet the inclusion criteria of these trials. The present study evaluates whether reduction of mortality by beta-blockers also can be achieved in patients pre...

During these more than 20 years of evolution in understandings the mechanisms heart failure (HF) with preserved fractional ejection, there has been a rich variety terminology, including „diastolic failure“, „heart systolic function“ and fraction“. By defi nition, latter term “ejection fraction-induced failure” proved to be most appropriate was accepted as correct, presence diastolic dysfunction ...

The association between type 2 diabetes mellitus (DM) and heart failure (HF) has been well-described for at least 4 decades (1), with DM increasing the risk of HF by 2to 6-fold (2). Based on these observations, DM was included as 1 of the criteria for the diagnosis of Stage A HF in the revised American College of Cardiology/American Heart Association (AHA) HF classification scheme introduced in...

heart failure (hf) is a condition due to a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. in developing countries, around 2% of adults suffer from heart failure, but in people over the age of 65, this rate increases to 6-10%. in iran, around 3.3% of adults suffer from heart failure. the health belief model (hbm) ...

BACKGROUND Physical activity (PA) predicts cardiovascular mortality in the population at large. Less is known about its prognostic value in patients with chronic heart failure (HF). METHODS AND RESULTS Data from 836 patients with implantable cardioverter defibrillator without or with cardiac resynchronization therapy enrolled in the Sensitivity of the InSync Sentry OptiVol feature for the pre...